Atara Biotherapeutics
(NASDAQ:ATRA)
$0.5265
-0.0034[-0.64%]
Last update: 2:48PM Get Real Time Here
Q1 2024 Earnings were released on Thu May 9th, after the market close
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Atara Biotherapeutics Stock (NASDAQ:ATRA), Quotes and News Summary

Atara Biotherapeutics Stock (NASDAQ: ATRA) stock price, news, charts, stock research, profile.

Open$0.541
Close-
Volume / Avg.1.369M / 1.686M
Day Range0.484 - 0.550
52 Wk Range0.199 - 2.535
Market Cap$63.399M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
28
Short Interest
9.65%
Days to Cover10.1

Recent News

Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) rose sharply in today’s pre-market trading. 4DMT presented interim data from randomized Phase 2 PRISM clinical trial of intravitreal 4D-150 demonstrating favorable tolerability & clinical activity in wet AMD.
Avi Kapoor
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results.
Avi Kapoor
Why Rocket Lab Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Shares of Rocket Lab USA, Inc. (NASDAQ: RKLB) shares rose sharply in pre-market trading after the company announced a new $515 million contract with a U.S. government customer.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
0
0
0
0
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
2.8
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ATRA
KZR

FAQ

Q

How do I buy Atara Biotherapeutics (ATRA) stock?

A

You can purchase shares of Atara Biotherapeutics (NASDAQ: ATRA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Atara Biotherapeutics's (ATRA) competitors?

A

Other companies in Atara Biotherapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), CARISMA Therapeutics (NASDAQ:CARM), Eagle Pharmaceuticals (NASDAQ:EGRX), Aligos Therapeutics (NASDAQ:ALGS) and MAIA Biotechnology (AMEX:MAIA).

Q

What is the target price for Atara Biotherapeutics (ATRA) stock?

A

The latest price target for Atara Biotherapeutics (NASDAQ: ATRA) was reported by Stifel on Monday, April 1, 2024. The analyst firm set a price target for 2.30 expecting ATRA to rise to within 12 months (a possible 336.85% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Atara Biotherapeutics (ATRA)?

A

The stock price for Atara Biotherapeutics (NASDAQ: ATRA) is $0.5265 last updated Today at May 13, 2024 at 2:48 PM EDT.

Q

Does Atara Biotherapeutics (ATRA) pay a dividend?

A

There are no upcoming dividends for Atara Biotherapeutics.

Q

When is Atara Biotherapeutics (NASDAQ:ATRA) reporting earnings?

A

Atara Biotherapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.

Q

Is Atara Biotherapeutics (ATRA) going to split?

A

There is no upcoming split for Atara Biotherapeutics.

Q

What sector and industry does Atara Biotherapeutics (ATRA) operate in?

A

Atara Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch